Precision Medicine for CLL

Jennifer Brown, MD, PhD

Video Categories: Personalized Medicine

Dr. Jennifer R. Brown deliberates on the state of personalized medicine in relation to CLL. She explains that the targeted drugs currently used for CLL actually work for most patients, rather than just a subgroup. Also, CLL therapies are now generally in pill form and well tolerated with few side effects.
October 23, 2018

Dealing with Issues of Obtaining Sufficient Tissue in Performing Biomarker Testing

Drs. Roy Herbst and David Rimm review some of the problems associated with obtaining enough tissue to perform biomarker testing, the need to triage tissue to ensure that standard of care tests are completed, and the potential role of liquid biopsies

November 26, 2013

PMO Interview with the Innovator Series: Volume 7

Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.